Hantson Ludwig
CEO at ALEXION PHARMACEUTICALS INC; Corporate Vice President at BAX
- Sold, on record
- $7M
- Dollars the filings state
- Form 4 sales
- 6
- Latest Dec 31, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ALEXION PHARMACEUTICALS INCCEO
- BAXBAXTER INTERNATIONAL INCCorporate Vice President
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- BAX71,252 shares
- ALEXION PHARMACEUTICALS INC19,042 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale BAXUnusualSep 25 2012
Sold 36,059 shares at $61.54 ($2.2M)
Hantson Ludwig, Corporate Vice President
Sold 28.7% of holdings ($7.7M position)89,652 shares leftFirst sale on recordFiling
- 2 Form 4 sale BAXPlan not statedJan 28 +125 days
Sold 10,500 shares at $67.64 ($710k)
Hantson Ludwig, Corporate Vice President
Sold 10.8% of holdings ($6.6M position)87,005 shares leftFiling
- 3 Form 4 sale BAXPlan not statedJul 9 +527 days
Sold 24,693 shares at $76.00 ($1.9M)
Hantson Ludwig, Corporate Vice President
Sold 22.7% of holdings ($8.3M position)83,903 shares leftFiling
- 4 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedJan 2 +1273 days
Sold 2,553 shares at $121.63 ($311k)
Hantson Ludwig, CEO
Sold 6.6% of holdings ($4.7M position)36,172 shares leftFirst sale on recordFiling
- 5 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedFeb 8 +37 days
Sold 13,245 shares at $116.31 ($1.5M)
Hantson Ludwig, CEO
Sold 10.1% of holdings ($15.3M position)118,180 shares leftFiling
- 6 Form 4 sale ALEXION PHARMACEUTICALS INCPlan not statedDec 31 +326 days
Sold 3,244 shares at $95.85 ($311k)
Hantson Ludwig, CEO
Sold 2.1% of holdings ($14.8M position)150,696 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | ALEXION PHARMACEUTICALS INC | CEO | Form 4 sale | 3,244 | $311k | 2.1% | Plan not stated | SEC |
| Feb 8, 2018 | ALEXION PHARMACEUTICALS INC | CEO | Form 4 sale | 13,245 | $1.5M | 10.1% | Plan not stated | SEC |
| Jan 2, 2018 | ALEXION PHARMACEUTICALS INC | CEO | Form 4 sale | 2,553 | $311k | 6.6% | Plan not stated | SEC |
| Jul 9, 2014 | BAX | Corporate Vice President | Form 4 sale | 24,693 | $1.9M | 22.7% | Plan not stated | SEC |
| Jan 28, 2013 | BAX | Corporate Vice President | Form 4 sale | 10,500 | $710k | 10.8% | Plan not stated | SEC |
| Sep 25, 2012 | BAX | Corporate Vice President | Form 4 sale | 36,059 | $2.2M | 28.7% | Unusual | SEC |